SS
HRMY icon

Sunbelt Securities’s Harmony Biosciences HRMY Stock Holding History

Sunbelt Securities’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448 Sell
16
-13
-45% -$426 ﹤0.01% 2318
2025
Q4 		$1.08K Buy
29
+19
+190% +$625 ﹤0.01% 2037
2025
Q3 		$276 Buy
+10
New +$344 ﹤0.01% 2361

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sunbelt Securities's HRMY Position: Q1 2026 in Review

Sunbelt Securities reduced its Harmony Biosciences (HRMY) stake by 45% in Q1 2026, selling an estimated $426 and leaving 16 shares worth $448. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Sunbelt Securities first reported a position in HRMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.08K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Sunbelt Securities held 16 shares of Harmony Biosciences worth $448 as of Q1 2026.
  • Sunbelt Securities sold 13 Harmony Biosciences shares in Q1 2026, an estimated $426.
  • Harmony Biosciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2318 holding.
  • Sunbelt Securities first reported a position in Harmony Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Harmony Biosciences position peaked at $1.08K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.